Time to Reconsider Calcium-Based Phosphate Binders in Dialysis? A Call for a Well-Designed Randomized Controlled Trial
-
Published:2020-03
Issue:3
Volume:75
Page:453-455
-
ISSN:0272-6386
-
Container-title:American Journal of Kidney Diseases
-
language:en
-
Short-container-title:American Journal of Kidney Diseases
Reference15 articles.
1. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study;Block;Am J Kidney Dis,1998
2. Phosphate-binder use in US dialysis patients: prevalence, costs, evidence, and policies;St. Peter;Am J Kidney Dis,2018
3. Pleiotropic effects of the non-calcium phosphate binder sevelamer;Nicolov;Kidney Int Suppl,2006
4. Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease;Hill;Kidney Int,2013
5. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease;Blacker;Hypertension,2001
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献